No PHI 15-minute fit review for GLP-1 clinics
Catch GLP-1 refill, side-effect, access, and confidence risks between visits.
PulseLog by HealthPulseAI turns no-PHI weekly check-ins into a staff-ready intervention queue for weight-loss, primary-care, DPC, metabolic, and medspa teams running GLP-1 programs.
First review uses synthetic or de-identified operational data only. Real patient identifiers, PHI, production storage, and live clinic workflows require HIPAA/BAA/compliance approval before use.
30-day pilot shape
1 clinic / 25–50 GLP-1 patients
Start with synthetic PulseLog check-ins, then graduate only after compliance sign-off.
- • Weekly green/yellow/red intervention queue
- • Side-effect, hydration, and confidence risk trends
- • Refill/access and coverage-friction report
- • Staff action readout and continuation recommendation
Why this wedge is urgent now
A 2025 JAMA Network Open cohort study of adults with overweight or obesity reported that most patients discontinued GLP-1 therapy within one year, with higher discontinuation among patients without type 2 diabetes. Clinics do not need another broad wellness app; they need earlier signals that a patient is about to miss, pause, ration, or abandon therapy.
Source: JAMA Network Open, Discontinuation and Reinitiation of GLP-1 Receptor AgonistsSynthetic queue mockup
Staff see who needs action before the next scheduled visit.
Example rows below are synthetic aliases. They illustrate the staff workflow without exposing patient names, contact details, prescription identifiers, or clinical notes.
PT-014Red
Signal: Missed dose + dehydration concern
Next action: Clinician escalation policy
PT-022Yellow
Signal: Refill/access issue
Next action: Staff access check
PT-031Yellow
Signal: Nausea score increased
Next action: Side-effect protocol review
PT-047Green
Signal: Dose taken, confidence stable
Next action: Routine encouragement
What the first pilot can include
- • Patient alias only
- • Medication family
- • Dose phase
- • Dose taken / missed / delayed
- • Side-effect severity bands
- • Refill, access, and coverage friction
- • Confidence score
- • Staff follow-up requested
What must stay out of the first request
- • Names or initials
- • Date of birth
- • MRN or prescription IDs
- • Phone numbers or emails
- • Addresses or member IDs
- • Screenshots or portal messages
- • Free-text clinical notes
After you request a review
The first step is a 15-minute no-PHI fit review, not a data handoff.
Clinic teams get a clear operating discussion before any pilot is approved: who owns follow-up, which non-identifying signals matter, and whether a 30-day PulseLog pilot is worth scoping.
1. Confirm the workflow owner
Identify who owns between-visit GLP-1 follow-up without sending patient charts, exports, or screenshots.
2. Map the no-PHI pilot queue
Use synthetic examples to choose the refill, side-effect, access, and confidence signals staff would review weekly.
3. Decide on the 30-day pilot fit
Leave with a scoped go/no-go note, compliance prerequisites, and next-step owner before any live workflow.
Onsite fit-review request
Request the PulseLog GLP-1 pilot packet without leaving this page.
Share clinic-level workflow context only. The request is saved to the existing pilot lead queue so the review does not depend on a local email application opening successfully.
Want the 30-day pilot packet?
We will review fit, clinic workflow, and no-PHI pilot inputs before discussing any live patient-data or production workflow. Do not include PHI in the public request.
Request GLP-1 pilot review